Launching DTC models requires navigating regulatory and licensing rules.
Spreeha Choudhury, JD, PharmD
Advertisement
Articles by Spreeha Choudhury, JD, PharmD
The idea of denying people proven medicines in the name of research has a dark legacy in this country.
Advertisement
Latest Updated Articles
Navigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-To-Consumer ProgramsPublished: October 10th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Sanofi Reaches Deals with ADEL for Novel Alzheimer’s Disease Drug, Dren Bio for B-cell Depletion Therapy
2
FDA Grants National Priority Voucher to Tecvayli Combination in Relapsed or Refractory Multiple Myeloma
3
FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer
4
Brent Saunders: Eyeing New Horizons
5
